CN104491060A - 预防脑胶质瘤复发的中药 - Google Patents

预防脑胶质瘤复发的中药 Download PDF

Info

Publication number
CN104491060A
CN104491060A CN201410728716.3A CN201410728716A CN104491060A CN 104491060 A CN104491060 A CN 104491060A CN 201410728716 A CN201410728716 A CN 201410728716A CN 104491060 A CN104491060 A CN 104491060A
Authority
CN
China
Prior art keywords
parts
chinese medicine
glioma
portions
cerebral glioma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410728716.3A
Other languages
English (en)
Inventor
郑伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taishan Medical University
Original Assignee
Taishan Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taishan Medical University filed Critical Taishan Medical University
Priority to CN201410728716.3A priority Critical patent/CN104491060A/zh
Publication of CN104491060A publication Critical patent/CN104491060A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/646Arachnids, e.g. spiders, scorpions, ticks or mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/65Amphibians, e.g. toads, frogs, salamanders or newts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/03Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

预防脑胶质瘤复发的中药,它涉及一种中药。它解决了脑胶质瘤术后病人出现复发的缺点,尽早应用能促进病人更快的恢复,延缓或者消除了胶质瘤的复发给患者、家庭及社会造成极大的危害,预防胶质瘤复发的中药按重量份数比包括30份仙鹤草、30份黄芪、30份当归、25份海藻、25份昆布、20份三七、15份红豆杉、15份桃仁、15份红花、15份金银花、15份连翘、15份蒲公英、10份灵芝、10份炙甘草。本发明预防脑胶质瘤复发的中药无毒性中药成分,无毒副作用,成本低,可用于各种脑胶质瘤术后(或无法行手术治疗的胶质瘤患者)的治疗,疗程为20-30天左右,疗效好,有效率达100%,治愈率达60%以上。

Description

预防脑胶质瘤复发的中药
技术领域
本发明涉及一种中药。
背景技术
脑胶质瘤(脑胶质细胞瘤)约占颅内肿瘤的46%。世界卫生组织1998年公布按死亡率顺序排位,恶性胶质瘤是34岁以下肿瘤患者的第2位死亡原因,是35~54岁患者的第3位死亡原因。胶质细胞瘤恶性程度低者生长缓慢,病程较长,自出现症状至就诊时间平均两年,恶性者瘤体生长快,病程短,自出现症状到就诊时多数在3个月之内。随着科学技术的进步,脑胶质瘤可采取手术切除,放疗、化疗等多种手段,但脑胶质瘤复发仍居高不下,给脑胶质瘤患者家庭及整个社会造成极大地影响。
发明内容
本发明的目的是为了解决脑胶质瘤术后病人很快复发的问题,脑胶质瘤术后尽早给药,早期进行干预,以消除或延缓脑胶质瘤的复发。预防脑胶质复发的中药按重量份数比包括30份仙鹤草、30份黄芪、30份当归、25份海藻、25份昆布、20份三七、15份红豆杉、15份桃仁、15份红花、15份金银花、15份连翘、15份蒲公英、10份灵芝、10份炙甘草。本发明预防脑胶质瘤复发的中药无毒性中药成分,无毒副作用,取材容易,成本低廉,制备方便,见效快。疗程为20-30天左右,疗效好,有效率达100%,治愈率达60%以上。
本发明中药材仙鹤草——功用主治:收敛止血,补虚,消积,止痢,杀虫,解毒消肿。用来治疗咯血、吐血等多种出血症,泄泻,痢疾,疮疖痈肿,蛔虫、绦虫等虫证以及脱力劳伤,神疲乏力,面色萎黄等证。
黄芪——功用主治:益气固表,敛汗固脱,托疮生肌,利水消肿。用于治疗气虚乏力,中气下陷,久泻脱肛,便血崩漏,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴,慢性肾炎,蛋白尿,糖尿病等。
当归——功能主治:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。
海藻——功用主治:软坚,消痰,利水,泄热。治瘰疬,瘿瘤,积聚,水肿,脚气,睾丸肿痛。
昆布——功用主治:软坚散结,消痰,利水。用于瘿瘤,瘰疬,睾丸肿痛,痰饮水肿。
三七——功用主治:止血,散瘀,消肿,定痛。 治吐血,咳血,衄血,便血,血痢,崩漏,症瘕,产后血晕,恶露不下,跌扑瘀血,外伤出血,痈肿疼痛。
红豆杉——功用主治:利尿消肿、防癌治癌。治疗白血病、肾炎、糖尿病以及多囊性肾病及各种癌症。
桃仁——功能主治:活血祛瘀,润肠通便,止咳平喘。用于经闭,痛经,癓瘕痞块,跌扑损伤,肠燥便秘。
  红花——功能主治:活血通径,散瘀止痛。主治产后血晕,瘀滞腹痛,胸痹心痛,血积,跌打瘀肿,关节疼痛,中风瘫痪,斑疹紫暗,痛经,经闭。
金银花——功用主治:清热解毒,凉散风热。用于痈肿疔疮,喉痹,丹毒,热血毒痢,风热感冒,温病发热。
连翘——功用主治:清热解毒,散结消肿。主治热病,风热感冒,发热,心烦,咽喉肿痛,斑疹,丹毒,瘰疬,痈疮肿毒,急性肾炎,热淋。
蒲公英——功用主治:清热解毒;消痈散结 主治:乳痈;肺痈;肠痈;痄腮;疔毒疮肿;目赤肿痛;感冒发热;咳嗽;咽喉肿痛;胃火;肠炎;痢疾;肝炎;胆吓炎;尿路感染;蛇虫咬伤。
灵芝——功用主治:滋补强壮.用于健脑,消炎,利尿,益肾。主治虚劳、咳嗽、气喘、失眠、消化不良,恶性肿瘤等。
炙甘草——功用主治:补脾和胃,益气复脉。用于脾胃虚弱,倦怠乏力,心动悸,脉结代。
具体实施方式
具体实施方式一:本实施方式预防脑胶质瘤复发的中药按重量份数比由30份仙鹤草、30份黄芪、30份当归、25份海藻、25份昆布、20份三七、15份红豆杉、15份桃仁、15份红花、15份金银花、15份连翘、15份蒲公英、10份灵芝、10份炙甘草组成。
本实施方式的预防脑胶质瘤复发的中药以软坚散结,消痰,利水,清热解毒,益气活血为理论基础进行组药。可将本实施方式中的中药饮片粉碎成小于100目的粉末后按重量份数比混合均匀,直接制成胶囊。
用法用量:脑胶质瘤术后病人病情较平稳后(或发现不适合手术病人)立即给药,每日服药3次,每次服用药物成分10克,孕妇忌用,服药期间不能进食海鲜、生冷、辛辣等刺激性食物。
表1是本实施方式预防脑胶质瘤术后复发的临床药效学报告,其中治愈:症状或客观检查阳性征象消失(CT或MRI);有效:症状明显改善,留有部分症状或明显延长病人的生存期;无效:症状及客观体征无改善或轻微改善。
表1是120例年龄在26-63岁的脑胶质瘤术后(或发现不能手术病人)应用此中药的治疗情况,病情诊断采信正规医院出具的报告。
表1 (单位:人)
服用本实施方式预防脑胶质瘤术后复发的中药并配合针灸、气功、心理治疗,治疗效果更为显著,治愈率高于60%。
    预防脑胶质瘤术后复发的中药在治愈后本实施方式还要继续服药7-10天以巩固疗效,并定期体检。
     具体实施方式二:本实施方式与具体实施方式一的不同点是:预防脑胶质瘤术后复发的中药按重量份数比由30份仙鹤草、30份黄芪、30份当归、25份海藻、25份昆布、20份三七、15份红豆杉、15份桃仁、15份红花、15份金银花、15份连翘、15份蒲公英、10份灵芝、 10份土鳖虫、10份穿山甲、10份水蛭、10份牡蛎、10份炙甘草组成。
  本实施方式中增加的中药材土鳖虫——功用主治:破血逐瘀;续筋接骨。 主治:血瘀经闭,癥瘕积块;跌打瘀肿;筋骨骨折;木舌重舌。
穿山甲——功用主治:消肿溃痈,搜风活络,通经下乳。治痈疽疮肿,风寒湿痹,月经停闭,乳汁不通,外用止血。
水蛭——功用主治:破血,逐瘀,通经。治蓄血,癥瘕,积聚,妇女经闭,干血成痨,跌扑损伤,目亦痛,云翳。
牡蛎——功用主治:敛阴,潜阳,止汗,涩精,化痰,软坚。治惊痫,眩晕,自汗,盗汗,遗精,淋浊,崩漏,带下,瘰疬,瘿瘤。用于惊悸失眠,眩晕耳鸣,瘰疠痰核,瘕痞块,自汗盗汗,遗精崩带,胃痛泛酸。
表2是本实施方式预防发生在大脑半球的脑胶质瘤术后预防复发的临床药效学报告,本实施方式预防发生在大脑半球的脑胶质瘤的治疗效果显著。治愈率高于64%。
表2 (单位:人)
具体实施方式三:本实施方式与具体实施方式一的不同点是:预防脑胶质瘤术后复发的中药按重量份数比由30份仙鹤草、30份黄芪、30份当归、25份海藻、25份昆布、20份三七、15份红豆杉、15份桃仁、15份红花、15份金银花、15份连翘、15份蒲公英、15份西洋参、10份灵芝、10份炙甘草、3份蟾蜍、3份全蝎组成。
本实施方式中增加的中药材西洋参——功用主治:益肺阴,清虚火,生津止渴。用于气虚阴亏,内热、咳喘痰血,虚热烦倦,消渴,口燥咽干。
蟾蜍——功用主治:清热解毒,利水消胀。 治痈疽,肿毒,瘰疬,肿瘤,疳积腹胀,慢性气管炎。
全蝎——功用主治:祛风,止痉,通络,解毒。治惊风抽搐,癫痫,中风、半身不遂、口眼歪斜,偏头痛,风湿痹痛,破伤风,淋巴结结核,风疹疮肿。
    表3是本实施方式用于预防发生在小脑的脑胶质瘤术后的临床药学报告,本实施方式预防发生在小脑半球的脑胶质瘤术后患者效果显著,治愈率高于60%。
    表3 (单位:人)
发生在小脑半球的脑胶质瘤术后的患者 治愈 有效 无效
65 40 25 0

Claims (3)

1.预防脑胶质瘤复发的中药,其特征在于预防脑胶质瘤复发的中药按重量份数比包括30份仙鹤草、30份黄芪、30份当归、25份海藻、25份昆布、20份三七、15份红豆杉、15份桃仁、15份红花、15份金银花、15份连翘、15份蒲公英、10份灵芝、10份炙甘草。
2.根据权利要求1所述的预防脑胶质瘤复发的中药,其特征在于预防脑胶质瘤复发的中药按重量份数比还包括10份土鳖虫、10份穿山甲、10份水蛭、10份牡蛎。
3.根据权利要求1所述的预防脑胶质瘤复发的中药,其特征在于预防脑胶质瘤复发的中药按份数比还包括15份西洋参、3份蟾蜍、3份全蝎。
CN201410728716.3A 2014-12-05 2014-12-05 预防脑胶质瘤复发的中药 Pending CN104491060A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410728716.3A CN104491060A (zh) 2014-12-05 2014-12-05 预防脑胶质瘤复发的中药

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410728716.3A CN104491060A (zh) 2014-12-05 2014-12-05 预防脑胶质瘤复发的中药

Publications (1)

Publication Number Publication Date
CN104491060A true CN104491060A (zh) 2015-04-08

Family

ID=52932574

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410728716.3A Pending CN104491060A (zh) 2014-12-05 2014-12-05 预防脑胶质瘤复发的中药

Country Status (1)

Country Link
CN (1) CN104491060A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012745A (zh) * 2015-07-30 2015-11-04 武志鹏 一种用于脑胶质瘤术后恢复的药物
CN106822844A (zh) * 2017-03-16 2017-06-13 河南中医药大学 一种预防脑胶质瘤术后复发的中药组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579677A (zh) * 2012-04-08 2012-07-18 许从玉 一种治疗脑胶质瘤的中药组合物
CN103251880A (zh) * 2013-03-08 2013-08-21 翁捷 一种治疗肿瘤的药物组合物及其制备方法
CN103520360A (zh) * 2013-10-16 2014-01-22 中国海洋大学 一种中药复方制剂、其制备方法及其应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102579677A (zh) * 2012-04-08 2012-07-18 许从玉 一种治疗脑胶质瘤的中药组合物
CN103251880A (zh) * 2013-03-08 2013-08-21 翁捷 一种治疗肿瘤的药物组合物及其制备方法
CN103520360A (zh) * 2013-10-16 2014-01-22 中国海洋大学 一种中药复方制剂、其制备方法及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
周洁等: "脑瘤散治疗复发性脑胶质瘤的临床研究", 《天津中医药》 *
杜德元: "中医论治肿瘤的研究进展", 《辽宁中医杂志》 *
杨锋等: "康得方抗肿瘤作用的实验研究", 《中国中医药科技》 *
王岩: "三芪抗瘤汤治疗脑胶质瘤术后60 例临床观察", 《河北中医药学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012745A (zh) * 2015-07-30 2015-11-04 武志鹏 一种用于脑胶质瘤术后恢复的药物
CN106822844A (zh) * 2017-03-16 2017-06-13 河南中医药大学 一种预防脑胶质瘤术后复发的中药组合物
CN113967244A (zh) * 2017-03-16 2022-01-25 河南中医药大学 一种预防脑胶质瘤术后复发的中药组合物、药物及其制备方法和应用

Similar Documents

Publication Publication Date Title
CN100417403C (zh) 治疗癌症的中药
CN103071093B (zh) 一种治疗妇科疾病的药物
CN100556446C (zh) 治疗肝癌的中药
CN104606352A (zh) 复方骨结核丸
CN103861046A (zh) 一种治疗三叉神经痛的中药
CN105343724A (zh) 一种治疗妇科疾病的中药组合物
CN105213974A (zh) 一种治疗淋巴瘤的中药组合物及其应用
CN103656365B (zh) 一种治疗心肝阴虚证型甲亢的中药
CN104491060A (zh) 预防脑胶质瘤复发的中药
CN107412640B (zh) 一种用于辅助针灸理疗的外用药膏
CN104491775A (zh) 治疗脑出血后抑郁症的中药
CN102266435B (zh) 一种专治牛皮癣的中药
CN103920046A (zh) 一种用于治疗膀胱炎的药物及制备方法
CN103417788B (zh) 一种治疗骨折内服中药
CN102579607B (zh) 一种治疗痤疮的中药组合物
CN105194572A (zh) 一种治疗胶质瘤的中药组合物
CN101647981B (zh) 一种治疗血虚风燥型牛皮癣的药物
CN104383453A (zh) 治疗脑外伤后狂躁症的中药
CN103041085A (zh) 一种足浴护理治疗痛经的中药组合物及应用
CN101869629B (zh) 一种治疗肾结石的中药
CN104383417A (zh) 一种治疗乳腺癌的药物
CN105287798A (zh) 降脂瘦身复原丸
CN105194588A (zh) 一种治疗肝硬化的中药制剂
CN104645233A (zh) 一种治疗乳腺增生的中药制剂
CN104587297A (zh) 一种治疗硬皮症的中药胶囊及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150408